Conmed Corp
General ticker "CNMD" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.3B
Conmed Corp does not follow the US Stock Market performance with the rate: -26.4%.
Estimated limits based on current volatility of 2.0%: low 67.82$, high 70.58$
Factors to consider:
- Company pays dividends: last record date 2024-12-20, amount 0.20$ (Y1.16%)
- Current price 28.1% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [96.16$, 146.47$]
- 2024-12-30 to 2025-12-30 estimated range: [118.64$, 172.55$]
Financial Metrics affecting the CNMD estimates:
- Positive: Non-GAAP EPS, $ of 3.45 > 2.29
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
- Positive: 9.05 < Operating profit margin, % of 9.69
- Positive: -0.96 < Investing cash flow per share, $ of -0.65
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 2.73
Short-term CNMD quotes
Long-term CNMD plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $1,010.63MM | $1,045.47MM | $1,244.74MM |
Operating Expenses | $900.92MM | $975.42MM | $1,124.14MM |
Operating Income | $109.72MM | $70.05MM | $120.60MM |
Non-Operating Income | $-36.61MM | $-140.92MM | $-39.77MM |
Interest Expense | $35.48MM | $28.91MM | $39.77MM |
R&D Expense | $43.56MM | $47.15MM | $52.60MM |
Income(Loss) | $73.11MM | $-70.86MM | $80.83MM |
Taxes | $10.56MM | $9.72MM | $16.37MM |
Profit(Loss) | $62.54MM | $-80.58MM | $64.46MM |
Stockholders Equity | $785.43MM | $745.54MM | $834.22MM |
Inventory | $231.64MM | $332.32MM | $318.32MM |
Assets | $1,766.02MM | $2,297.59MM | $2,300.02MM |
Operating Cash Flow | $111.77MM | $33.37MM | $125.35MM |
Capital expenditure | $14.87MM | $21.79MM | $19.03MM |
Investing Cash Flow | $-14.87MM | $-249.53MM | $-20.03MM |
Financing Cash Flow | $-101.55MM | $225.00MM | $-110.43MM |
Earnings Per Share* | $2.14 | $-2.68 | $2.10 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.